Exosomes and immune modulation: implications for neuroblastoma immunotherapy

Exosomes and immune modulation: implications for neuroblastoma immunotherapy

Exosomes are nano-sized extracellular vesicles involved in cell homeostasis. Tumor-derived exosomes (TDEs) promote tumor progression by creating an immunosuppressive tumor microenvironment (TME), inhibiting T and NK cell activity, preventing dendritic cell maturation, and expanding immunosuppressive...

Full description

Saved in:

Bibliographic Details
Main Authors:	Martina Morini, Chiara Vitale, Martina Ardito, Alessandra Dondero, Katia Cortese, Cristina Bottino, Roberta Castriconi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Immunology
Subjects:	exosomes immunotherapy tumor microenvironment neuroblastoma NK cells cancer stem cells
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1600062/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Engineering neuroblastoma models for clinical translation
by: Taiyu Song, et al.
Published: (2025-01-01)

Tumor-derived exosomes and their application in cancer treatment
by: Afsaneh Javdani-Mallak, et al.
Published: (2025-07-01)

Editorial: Immune cell therapy approaches targeting tumor microenvironment
by: Santosh K. Patnaik, et al.
Published: (2025-05-01)

NK cells expansion <i>in vitro</i> is followed by loss of inhibitory KIR expression
by: N. A. Alekseeva, et al.
Published: (2023-06-01)

Monitoring Biochemical Changes of Neuroblastoma Cells in Early Stages After X-Ray Exposure by Using Fourier-Transform Infrared Spectroscopy
by: Rosario Esposito, et al.
Published: (2024-11-01)

Treatment outcome in a patient with triple-negative breast cancer using adoptive immunotherapy
by: E. V. Abakushina, et al.
Published: (2025-07-01)

Corrigendum to “Gene engineered exosome reverses T cell exhaustion in cancer immunotherapy” [Bioact. Mater. 34 (2024) 466–481]
by: Peishan Li, et al.
Published: (2025-10-01)

c-Jun promotes neuroblastoma cell differentiation by inhibiting APC formation via CDC16 and reduces neuroblastoma malignancy
by: Yunyun Wang, et al.
Published: (2025-03-01)

Advances and obstacles of T cell-based immunotherapy in gynecological malignancies
by: Xi Zhao, et al.
Published: (2025-07-01)

Radiotherapy-derived engineered stem cell exosomes improve anti-glioma immunotherapy by promoting the formation of tertiary lymphoid structure and improve the release of type I interferon
by: Man Li, et al.
Published: (2025-03-01)

Circulating tumor cells and clusters as liquid biomarkers for the diagnosis and prognosis of neuroblastoma
by: Huanli Xu, et al.
Published: (2025-07-01)

Application and prospects of genetic engineering in CAR-NK cell therapy
by: Caidong Hu, et al.
Published: (2025-05-01)

S100A11 as an immune-related exosomal driver of colorectal cancer progression: a novel diagnostic biomarker
by: Haibo Wang, et al.
Published: (2025-06-01)

Neuroblastoma presenting as haemophagocytic lymphohistiocytosis
by: Monika Pogorzala
Published: (2025-04-01)

Nanotechnology and natural killer cell immunotherapy: synergistic approaches for precise immune system adjustment and targeted cancer treatment in gastrointestinal tumors
by: Xiwen Kang, et al.
Published: (2025-08-01)

Inhibition of autophagy enhances the antitumor efficacy of T/CAR T cell against neuroblastoma
by: Francesca De Mitri, et al.
Published: (2025-07-01)

Dendritic cell-derived exosomes as anti-cancer cell-free agents: new insights into enhancing immunogenic effects
by: Tikhon Redkin, et al.
Published: (2025-05-01)

Molecular genetic features of neuroblastoma in adolescent
by: N. A. Andreeva, et al.
Published: (2024-06-01)

Local delivery of dinutuximab from lyophilized silk fibroin foams for treatment of an orthotopic neuroblastoma model
by: Kimberly J. Ornell, et al.
Published: (2020-04-01)

Targeting netrin‐3 in small cell lung cancer and neuroblastoma
by: Shan Jiang, et al.
Published: (2021-03-01)

Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer Treatment
by: Hyukmin In, et al.
Published: (2025-02-01)

PECULIARITIES OF NK CELLS DIFFERENTIATION: CD56dim AND CD56bright NK CELLS AT PREGNANCY AND IN NON-PREGNANT STATE
by: V. A. Mikhailova, et al.
Published: (2017-01-01)

Nanomanaging Chronic Wounds with Targeted Exosome Therapeutics
by: Anita Yadav, et al.
Published: (2025-03-01)

CD2AP shapes a stromal reduced tumor microenvironment and contributes to immunotherapy in gastric cancer
by: Haoliang Li, et al.
Published: (2025-05-01)

Neuroblastoma in a Case with Congenital Horner’s Syndrome
by: Hüseyin Mayalı, et al.
Published: (2014-08-01)

POSTTREATMENT NEUROBLASTOMA MATURATION TO GANGLIONIC CELL TUMOR
by: M. V. Ryzhova, et al.
Published: (2015-04-01)

Olfactory domain family protein 3 promotes the proliferation of MYCN-amplified neuroblastoma cell lines in vitro
by: ZHANG Yao, ZHANG Xuan, JIA Anna, ZHAN Shijia, GUO Jinxin, CHANG Yan, GUO Yongli
Published: (2025-02-01)

Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma
by: Kimberley M. Hanssen, et al.
Published: (2025-08-01)

Sulfafurazole dimers potentiate chemo-immunotherapy of low immunogenic breast cancer by preventing the PD-L1 exosomes secretion
by: Zheng Wang, et al.
Published: (2025-05-01)

Natural carrier systems in cancer vaccines and immunotherapy
by: Iman Owliaee, et al.
Published: (2025-12-01)

Metronomic chemotherapy in pediatric neuroblastoma
by: Yi Jiang, et al.
Published: (2024-12-01)

Integrated single-cell and transcriptomic analysis of bone marrow-derived metastatic neuroblastoma reveals molecular mechanisms of metabolic reprogramming
by: Jing Chu, et al.
Published: (2025-08-01)

Regulation of the cytokine profile of NK cells by the microenvironment factors typical for pregnancy
by: P. V. Grebenkina, et al.
Published: (2025-03-01)

Current challenges and emerging opportunities of chimeric antigen receptor-engineered cell immunotherapy
by: Yong Liu, et al.
Published: (2025-07-01)

Comprehensive analysis of exosome-related gene signature in multiple myeloma prognosis and immune microenvironment evaluation
by: Dong Zheng, et al.
Published: (2025-07-01)

Cell death pathway regulation by fatty acid metabolism-related genes in neuroblastoma: a multi-omics analysis identifying CHD5 as a novel biomarker
by: Yankun Chen, et al.
Published: (2025-03-01)

Exosome-Mediated Chemoresistance in Cancers: Mechanisms, Therapeutic Implications, and Future Directions
by: Gengqi Liu, et al.
Published: (2025-05-01)

Analysis of factors influencing platelet transfusion in children with high-risk stage Ⅳ neuroblastoma undergoing autologous hematopoietic stem cell transplantation
by: FU Xiaoyan, et al.
Published: (2025-07-01)

Machine learning-driven identification of exosome- related biomarkers in head and neck squamous cell carcinoma
by: Yaodong He, et al.
Published: (2025-05-01)

Role and practical guidelines for the use of radiotherapy in neuroblastoma — a narrative review of literature and clinical trial protocols
by: Aleksandra Jadwiga Sztuder, et al.
Published: (2025-01-01)